SILO.c teams up with Ehave, to study the transitions between SILO.c 's embarking on a fantastic study that will allow Ehave to deploy NeuroCap and NeuroEEG in order to capture the data around the electrophysiological changes in brain pre, mid, and post-psychedelic drug administration. revealing the effects of psilocybin molecules. advancing the understanding of the neurobiological underpinnings of immersive states of consciousness could ultimately help researchers find better treatment approaches for diseases such as chronic pain, depression (major and persistent), bipolar disorder, general anxiety, ADHD and Schizophrenia.